Nationwide Fund Advisors Athersys, Inc Transaction History

Nationwide Fund Advisors

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 01, 2018
SELL
$1.65 - $2.45 $92,772 - $137,753
-56,226 Closed
0 $0
Q3 2017

Oct 23, 2017
BUY
$1.5 - $2.55 $2,290 - $3,893
1,527 Added 2.79%
56,226 $116,000
Q2 2017

Aug 10, 2017
BUY
N/A
54,699
54,699 $83,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Nationwide Fund Advisors Portfolio

Follow Nationwide Fund Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Nationwide Fund Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email